Active Pharmaceutical Ingredients
| Product Name | CAS No. | Specification | Application | Registration |
| Osimertinib mesylate | 1421373-66-1 | 98+% | Anti-cancer | EGFR | |
| Osimertinib | 1421373-65-0 | 98+% | Anti-cancer research | EGFR | |
| Cagrilintide | 1415456-99-3 | 98+% | Research on the treatment of diabetes | CGRP Receptor | |
| Midostaurin | 120685-11-2 | 98+% | Anticancer Research | |
| Calicheamicin | 108212-75-5 | 98+% | Tumor antibiotics | |
| N-Acetyl-Calicheamicin | 108212-76-6 | 98+% | Cancer Targeted Therapy | |
| Tirzepatide | 2023788-19-2 | 98+% | Diabetes Models | |
| Semaglutide | 910463-68-2 | 98+% | Glucagon Receptor agonist | |
| Insulin Degludec | 844439-96-9 | 98+% | Insulin Receptor | |
| Insulin Aspart | 116094-23-6 | 98+% | Insulin Receptor | |
| GS-441524 | 1191237-69-0 | 98+% | DNA/RNA Synthesis | SARS-CoV | |
| Nifursol | 16915-70-1 | 98+% | veterinary antibiotic | |
| PPAR agonist 1 | 539813-69-9 | 98+% | PPAR | reducing blood glucose | |
| TH1020 | 1841460-82-9 | 98+% | Toll-like Receptor (TLR) | |
| Deucravacitinib | 1609392-27-9 | 99+% | JAK inhibitor | IFN inhibitor | Interleukins inhibitor |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Anti-Cancer (Oncology)
- Vitamin D Series Compounds
- Antibody-Drug Conjugates
- Prostaglandins
- Immunosuppressants
- Cardiovascular
- Antiviral Agents
- Anti-Diabetic
- Peptides
- Veterinary
- Antibacterial
- Miscellaneous
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn